Fig. 1From: Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy studyCorrelation between anti factor X (anti-FXa) assay and prothrombin time (PT). Dotted lines indicate the normal range, determined from the control groupBack to article page